CAS: 118949-61-4; 2,6-Bis((S)-4-Isopropyl-4,5-Dihydrooxazol-2-yl)Pyridine

该化合物是一种手性脉动脉动螺旋,其侧侧侧有2个(4S--)-异丙基-2-oxazoline moiety,其僵硬的定型结构使其在非对称催化中非常有效,特别是在C-C债券形成和对应选择性氢化等过渡性金属介质反应中.异丙基体组加强了...

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号329038-94-0 N,N'-bis-[(1S)-... | CAS号2893-33-6 2,6-吡啶二甲腈 | CAS号2026-48-4 L-缬氨醇 | CAS号329038-95-1 N2,N6-bis((S)-1... | CAS号3739-94-4 2,6-吡啶二甲酰氯 | CAS号499-83-2 2,6-吡啶二羧酸 | CAS号5431-44-7 2,6-吡啶二甲醛 | CAS号55309-58-5 pyridine-2,6-di...

合成工艺路线路线简述

  • 合成目标产物 (S,S)-2,6-Bis(4-Isopropyl-2-Oxazolin-2-yl)Pyridine 主要起始原料 Pyridine-2,6-Dicarboxylic Acid
  • (文献来源)合成步骤主要原料 Pyridine-2,6-Dicarboxylic Acid
2-N,6-N-Bis[(2S)-1-Chloro-3-Methylbutan-2-Yl]Pyridine-2,6-Dicarboxamide置于sodium Hydroxide体系中,用 甲醇,水 用作溶剂,化学反应 72.0H,以1.22 G的收率获得(S,S)-2,6-双(4-异丙基-2-恶唑啉-2-基)吡啶
参考文献:带有吡啶双恶唑啉配体的二氯化钴配合物的合成,表征和1,3-丁二烯聚合反应的研究
标题:带有吡啶双恶唑啉配体的二氯化钴配合物的合成,表征和1,3-丁二烯聚合反应的研究
摘要:成功地合成了一系列带有吡啶双恶唑啉配体的离子对钴配合物,并通过红外光谱和元素分析对其进行了表征.通过x射线晶体学分析确定,络合物4A,4B,4E和4F作为由[col 2 ] 2+和[cocl 4 ] 2-组成的离子对存在.在该络合物中,钴原子被两个配体的六个氮原子配位,并且其配位几何在[col 2 ] 2+的钴中心可以形容为扭曲的八面体.与乙基倍半氯化铝结合使用时,这些钴配合物显示出较高的催化活性和对1,3-丁二烯聚合的顺式-1,4-选择性.催化体系的选择性可以通过添加pph 3调整为1,2-方式.还研究了反应参数和配体环境对聚合反应的影响.
Doi:10.1016/j.Polymer.2015.01.006

海关参考信息

专利信息


专利号:US-11926589-B2
优先权日:2019-07-09
标 题 :Process for the synthesis of non-racemic cyclohexenes
发明人:REISMAN SARAH; ROMBOLA MICHAEL; LADD CAROLYN L; MCLAUGHLIN MARTIN JOHN; ZUEND STEPHAN; GOETZ ROLAND
权利人:BASF CORP; CALIFORNIA INST OF TECHN
摘要:This invention relates to a process for the synthesis of a non-racemic cyclohexene compound of formula (I) by a Diels-Alder reaction of a compound of formula (II) with a compound of formula (III) wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 and Y have the meanings as defined in the description in the presence of a catalyst comprising at least one m-valent metal cation M m+ wherein the metal M is selected from Scandium (Sc), Yttrium (Y), Lanthanum (La), Cerium (Ce), Praseodymium (Pr), Neodymium (Nd), Promethium (Pm), Samarium (Sm), Europium (Eu), Gadolinium 15 (Gd), Terbium (Tb), Dysprosium (Dy), Holmium (Ho), Erbium (Er), Thulium (Tm), Ytterbium (Yb), Lutetium (Lu), Gallium (Ga) and Indium (In), and m is an integer of 1, 2 or 3, and a chiral ligand of the formula (IV) wherein R 10a , R 10b , R 10c , R 10d , R 10a′ , R 10b′ , R 10c′ , R 10d′ , Z and Z′ have the meanings as defined in the description.

专利号:EP-2644590-A1
优先权日:2012-03-30
标 题:Synthesis of 2-(3,4-difluorophenyl)cyclopropanamine derivatives and salts
权利人:LEK PHARMACEUTICALS
摘要:The present invention relates to the field of organic synthesis and describes the synthesis of specific intermediates suitable for the preparation of triazolopyrimidine compounds such as ticagrelor.

专利号:US-8735586-B2
优先权日:2007-06-26
标 题 :Regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazoles
发明人:ALONSO JORGE; LINDENSCHMIDT ANDREAS; NAZARÉ MARC; URMANN MATTHIAS; HALLAND NIS; RKYEK OMAR
权利人:ALONSO JORGE; LINDENSCHMIDT ANDREAS; NAZARÉ MARC; URMANN MATTHIAS; HALLAND NIS; RKYEK OMAR; SANOFI SA
摘要:The present invention relates to a process for the regioselective synthesis of compounds of the formula I, n nwherein R0; R1; R2; R3; R4; R5; A1; A2; A3; A4, Q and J have the meanings indicated in the claims. The present invention provides a direct copper catalyzed regioselective process to a wide variety of unsymmetrical, multifunctional N-substituted benzimidazoles or azabenzimidazoles of formula I starting from 2-halo-nitroarenes and N-substituted amides.

专利号:US-7893286-B2
优先权日:2007-06-01
标题 :Method for the synthesis of phospholipid ethers
发明人:PINCHUK ANATOLY; WEICHERT JAMEY P; LONGINO MARC
权利人:CELLECTAR INC
摘要:Disclosed are improved methods for the synthesis of phospholipid ether analogs and alkyl phosphocholine analogs. The methods allow greater versatility of the reactants used and greater ease in synthesizing alkyl chains of varying length while affording reaction temperatures at room temperature or below. The methods disclosed herein provide reactants and conditions using alkyl halides and organozinc reagents and do not utilize Gringard reactions thus, allowing greater ease of their separation and purity of products. The PLE compounds synthesized by the methods disclosed herein can also be used for synthesizing high specific activity phospholipid ether (PLE) analogs, for use in treatment and diagnosis of cancer.

专利号:EP-2173747-B1
优先权日:2007-06-26
标 题:A regioselective metal catalyzed synthesis of annelated benzimidazoles and azabenzimidazoles
发明人:ALONSO JORGE; LINDENSCHMIDT ANDREAS; NAZARE MARC; R KYEN OMAR; URMANN MATHIAS; HALLAND NIS
权利人:SANOFI SA
摘要:The present invention relates to a process for the regioselective synthesis of compounds of the formula I, wherein R1; R2; R3; R4; J1; J2; J3; J4 and G have the meanings indicated in the claims. The present invention provides a direct metal, e.g. palladium or copper, catalyzed, regioselective process to a wide variety of unsymmetrical, multifunctional N-substituted benzimidazoles or azabenzimidazoles of formula I starting from 2-halo-nitroarenes and N-substituted amides.

专利号:US-8022235-B2
优先权日:2007-06-01
标 题 :Compositions of phospholipid ether boronic acids and esters and methods for their synthesis and use
发明人:PINCHUK ANATOLY; WEICHERT JAMEY P; LONGINO MARC
权利人:CELLECTAR INC
摘要:The present invention discloses boronic acids and esters of phospholipid ether analogs and methods for their synthesis and use. The boronic acids and esters of phospholipid ether analogs described herein can be used in treating cancer and in particular can be used in conjunction with radiation therapy, such as external beam radiation therapy and neutron capture therapy to specifically target and kill cancer cells.
无锡惠飞生物医药技术有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.huifeichem.com
电话: 0510-0510-83593305👤
📞无锡惠飞生物医药技术有限公司 ⚠️参考联系方式

销售电话:0510-0510-83593305
邮箱:sales@huifeichem.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
宁波申泰生物科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.syntame.com
企业联系电话:0574-28802872👤
📞宁波申泰生物科技有限公司 ⚠️参考联系方式
联系人:陈女士
电话:0574-28802872

传真:0574-28802872
邮箱:Info@syntame.com
通信地址: 宁波市鄞州区下应北路789号锐鼎加速器2号楼
邮编: 315105
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:宁波市鄞州区下应北路789号锐鼎加速器2号楼
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


摘要:Li, W.; Liu, X. H.; Feng, X. M., Science of Synthesis Knowledge Updates, (2021) 1, 48.
摘要:Li, W.; Liu, X. H.; Feng, X. M., Science of Synthesis Knowledge Updates, (2021) 1, 11.
摘要:Huy, P.; Czekelius, C., Science of Synthesis Knowledge Updates, (2019) 2, 172.
摘要:Gnanaprakasam, B.; Chaudhari, M. B., Science of Synthesis Knowledge Updates, (2019) 2, 437.
摘要:Schneider, C.; Sickert, M., Science of Synthesis Knowledge Updates, (2017) 3, 316.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知